Clinical, quality of life, and economic value of acromegaly disease control

@inproceedings{BenShlomo2011ClinicalQO,
  title={Clinical, quality of life, and economic value of acromegaly disease control},
  author={A. B. Ben-Shlomo and Michael C. Sheppard and Jennifer M L Stephens and S. P{\'e}rez del Pulgar and Shlomo Melmed},
  booktitle={Pituitary},
  year={2011}
}
Although acromegaly is a rare disease, the clinical, economic and health-related quality of life (HRQoL) burden is considerable due to the broad spectrum of comorbidities as well as the need for lifelong management. We performed a comprehensive literature review of the past 12 years (1998–2010) to determine the benefit of disease control (defined as a growth hormone [GH] concentration <2.5 μg/l and insulin-like growth factor [IGF]-1 normal for age) on clinical, HRQoL, and economic outcomes… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 65 references

Similar Papers

Loading similar papers…